Market Research Reports

Melatonin Market for Food & Beverages, Dietary Supplements, Medicine and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

82pages
Published Date: 2014-05-02
 

Description


This report covers forecast and analysis for the melatonin market on a global and regional level. The study provides historic data of 2012 along with forecast from 2013 to 2019 based on both volumes (tons) and revenue (USD million). The study includes drivers and restraints for the melatonin market along with their impact on demand during the forecast period. Additionally, the report includes the study of opportunities available in the melatonin market on the global and regional level. 

In order to provide the users of this report with a comprehensive view of this market, we have included a detailed value chain analysis. An analysis of the Porter’s Five Forces model has also been included to help understand the competitive landscape in the market. The study encompasses market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general market attractiveness.

The study provides a decisive view of the melatonin market by segmenting the market based on both regions and applications. All the application segments have been analyzed based on present and future trends and the market has been estimated from 2013 to 2019. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the World (RoW) along with country specific demand and forecast for the U.S., China and Japan. This segmentation includes demand for individual applications in all the regions.

Market estimates for this study have been based on volumes, with revenues being derived through regional pricing trends. The price for commonly available grade of melatonin has been considered and customized product pricing has not been included. The market has been analyzed based on expected demand and the market data for each segment is based on demand volumes and corresponding revenues. The prices considered for calculation of revenue are average regional prices obtained through primary quotes from numerous regional suppliers, distributors and direct selling regional producers especially in Asia. We have considered prices of melatonin as per industry standard based on manufacturer feedback and application requirement. Market data is based on current information however, presence of a large number of domestic manufacturers in Asia Pacific may cause variation in forecast by a small margin. Forecasts have been based on expected demand from applications segments, primarily dietary supplements, medicine, food and beverage and others. We have used the bottom-up approach to arrive at the global market considering individual application segments and integrating them to arrive at the global market. The applications have been further bifurcated using the top-down approach to derive the regional product market consumption. The study covers the melatonin market taking into account the sales of registered companies in the market. We have not included unorganized sectors of the market due to the lack of secondary or primary data on this segment. Economic inflation has not been considered in the study during estimation and forecasts.

Several primary and secondary sources were consulted during the course of the study. Some of the secondary sources which were consulted were ICIS, National Sleep Foundation, European Medicines Agency, US Food and Drug Administration, Netdoctor (Publication of Hearst Magazines U.K.), NHS – National Health Service and MIMS (Monthly Index of Medical Specialties) among many others.

The report covers a detailed competitive outlook including market shares and company profiles of key participants operating in the global market. Key players profiled in the report include Neurim Pharmaceuticals, Flynn Pharma Ltd, Fidia Farmaceutici S.P.A., Natrol Inc, and Schiff Nutrition International Inc. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments. The market has been segmented as below:

Melatonin Market - Application Analysis
  • Dietary supplements
  • Medicine
  • Food & beverages
  • Others
The report provides a cross-sectional analysis of the above applications segments with respect to the following regions:

Melatonin Market - Regional Analysis
  • North America
    • U.S.
  • Europe
  • Asia-Pacific
    • China
    • Japan
  • Rest of the World

Table of Contents


Table of Content

Chapter 1 Preface
1.1 Research description
1.2 Market segmentation
      1.2.1 Global melatonin market segmentation, application and region
1.3 Research scope
1.4 Research methodology
      1.4.1 Assumptions
      1.4.2 Abbreviations

Chapter 2 Executive Summary
2.1 Global melatonin market, 2012 – 2019 (Tons) (USD Million)

Chapter 3 Global Melatonin - Industry Analysis
3.1 Introduction
3.2 Value chain analysis
3.3 Potential substitute of melatonin
3.4 Manufacturing Processes
      3.4.1 From 5 methoxyindole 3-acetonitrile
      3.4.2 From 5 methoxytryptamine (mexamine)
3.5 Market drivers
      3.5.1 Dietary supplements status in the US
      3.5.2 Increased stress level in younger generations
3.6 Market restraints
      3.6.1 Government body regulations
      3.6.2 Lack of awareness in Asia Pacific
3.7 Market opportunities
      3.7.1 Application in other diseases
      3.7.2 Potential market in China and India
3.8 Porter’s five forces analysis
      3.8.1 Bargaining power of suppliers
      3.8.2 Bargaining power of buyers
      3.8.3 Threat of new entrants
      3.8.4 Threat from substitutes
      3.8.5 Degree of competition
3.9 Melatonin: Market attractiveness analysis
      3.9.1 Global melatonin market: Market attractiveness analysis
3.10 Melatonin: Company market share analysis
      3.10.1 Global melatonin: Company market share analysis

Chapter 4 Melatonin Market – Application Analysis
4.1 Global melatonin market: Application segment overview
      4.1.1 Global melatonin market share, by application segment, 2012 & 2019
4.2 Dietary supplements
      4.2.1 .Global dietary supplements demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
4.3 Medicine
      4.3.1 Global medicine demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
4.4 Food and beverages
      4.4.1 Global food and beverages demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
4.5 Others
      4.5.1 Global others demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
4.6 Country-specific import condition for melatonin drugs
4.7 Country-specific popularity of melatonin supplements/drugs

Chapter 5 Melatonin Market - Regional Analysis
5.1 Global melatonin market: Regional overview
      5.1.1 Global melatonin market share, by region, 2012 & 2019
5.2 North America
      5.2.1 North America melatonin market volumes, by application segment, 2012 - 2019 (Tons)
      5.2.2 North America melatonin market revenues, by application segment, 2012 - 2019 (USD Million)
              5.2.2.1 U.S. melatonin market volumes, by application, 2012 - 2019 (Tons)
      5.2.3 U.S. melatonin market revenues, by application, 2012 - 2019 (USD Thousands)
5.3 Europe
      5.3.1 Europe melatonin market volumes, by application segment, 2012 - 2019 (Tons)
      5.3.2 Europe melatonin market revenues, by application segment, 2012 - 2019 (USD Million)
5.4 Asia Pacific
      5.4.1 Asia Pacific melatonin market volumes, by application segment, 2012 - 2019 (Tons)
      5.4.2 Asia Pacific melatonin market revenues, by application segment, 2012 - 2019 (USD Million)
              5.4.2.1 China melatonin market volumes, by application, 2012 - 2019 (Tons)
              5.4.2.2 China melatonin market revenues, by application, 2012 - 2019 (USD Thousand)
              5.4.2.3 Japan melatonin market volumes, by application, 2012 - 2019 (Tons)
              5.4.2.4 Japan melatonin market revenues, by application, 2012 - 2019 (USD Thousand)
5.5 Rest of the World (RoW)
      5.5.1 RoW melatonin market volumes, by application segment, 2012 - 2019 (Tons)
      5.5.2 RoW melatonin market revenues, by application segment, 2012 - 2019 (USD Million)

Chapter 6 Company Profiles
6.1 Natrol, Inc.
      6.1.1 Company overview
      6.1.2 Product portfolio
      6.1.3 Financial overview
      6.1.4 Business strategy
      6.1.5 SWOT analysis
      6.1.6 Recent developments
6.2 Neurim Pharmaceuticals Ltd.
      6.2.1 Company overview
      6.2.2 Product portfolio
      6.2.3 Business strategy
      6.2.4 SWOT analysis
      6.2.5 Recent developments
6.3 Pulse Pharmaceuticals Pvt Ltd
      6.3.1 Company overview
      6.3.2 Product portfolio
      6.3.3 Business strategy
      6.3.4 SWOT analysis
      6.3.5 Recent developments
6.4 Flynn Pharma Ltd.
      6.4.1 Company overview
      6.4.2 Product portfolio
      6.4.3 Business strategy
      6.4.4 SWOT analysis
      6.4.5 Recent developments
6.5 Fidia Farmaceutici S.P.A
      6.5.1 Company overview
      6.5.2 Product portfolio
      6.5.3 Financial overview
      6.5.4 Business strategies
      6.5.5 SWOT analysis
      6.5.6 Recent developments
6.6 Aspen Pharmacare Holdings Ltd.
      6.6.1 Company overview
      6.6.2 Product Portfolio
      6.6.3 Financial overview
      6.6.4 Business strategy
      6.6.5 SWOT analysis
      6.6.6 Recent developments
6.7 Schiff Nutrition International, Inc.
      6.7.1 Company overview
      6.7.2 Product portfolio
      6.7.3 Financial overview
      6.7.4 Business strategy
      6.7.5 SWOT analysis
      6.7.6 Recent development
6.8 Solal Technologies (Pty). Ltd.
      6.8.1 Company overview
      6.8.2 Product portfolio
      6.8.3 Business strategy
      6.8.4 SWOT analysis
6.9 Rexall Sundown, Inc.
      6.9.1 Company overview
      6.9.2 Product portfolio
      6.9.3 Business strategy
      6.9.4 SWOT analysis
      6.9.5 Recent development
6.10 Bebida Beverage Company
       6.10.1 Company overview
       6.10.2 Product portfolio
       6.10.3 Financial overview
       6.10.4 Business strategy
       6.10.5 SWOT analysis
       6.10.6 Recent development

List of Figures 

Fig. 1. Global melatoninmarket segmentation, application and region
Fig. 2. Global melatonin market, 2012 – 2019 (Tons) (USD Million)
Fig. 3. Melatonin: Value chain analysis
Fig. 4. Average stress level Vs. Healthy stress level
Fig. 5. Porter’s five forces analysis
Fig. 6. Melatonin: Market attractiveness analysis
Fig. 7. Global melatonin: Company market share analysis
Fig. 8. Global melatonin market share, by application segment, 2012 & 2019
Fig. 9. Global dietary supplements demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
Fig. 10. Global medicine demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
Fig. 11. Global food and beverages demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
Fig. 12. Global others demand for melatonin market, by application, 2012 - 2019, (Tons)(USD Million)
Fig. 13. Global melatonin market share by region, 2012 & 2019

List of Tables

TABLE 1 Global melatonin market snapshot
TABLE 3 Drivers for the melatonin market: Impact analysis
TABLE 4 Restraints for the melatonin market: Impact Analysis
TABLE 5 Restraints for melatonin market: Environmental regulations
TABLE 6 Country-specific import condition for melatonin drugs
TABLE 7 Country-specific popularity of melatonin supplements/drugs
TABLE 8 North America melatonin market volumes, by application, 2012 - 2019 (USD Million)
TABLE 9 North America melatonin market revenues, by application, 2012 - 2019 (USD Million)
TABLE 10 U.S. melatonin market volumes, by application, 2012 - 2019 (Tons)
TABLE 11 U.S. melatonin market revenues, by application, 2012 - 2019 (USD Thousand)
TABLE 12 Europe melatonin market volumes, by application, 2012 - 2019 (Tons)
TABLE 13 Europe melatonin market revenues, by application, 2012 - 2019 (USD Million)
TABLE 14 Asia Pacific melatonin market volumes, by application, 2012 - 2019 (Tons)
TABLE 15 Asia Pacific melatonin market revenues, by application, 2012 - 2019 (USD Million)
TABLE 16 China melatonin market volumes, by application, 2012 - 2019 (Tons)
TABLE 17 China melatonin market revenues, by application, 2012 - 2019 (USD Thousands)
TABLE 18 Japan melatonin market volumes, by application, 2012 - 2019 (Tons)
TABLE 19 Japan melatonin market revenues, by application, 2012 - 2019 (USD Thousands)
TABLE 20 RoW melatonin market volumes, by application, 2012 - 2019 (Tons)
TABLE 21 RoW melatonin market revenues, by application, 2012 - 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Melatonin is a naturally occurring hormone that is found in all living organisms in the animal and plant kingdom. In human beings, it is produced in the pineal gland, which is located in the posterior part of the third ventricle of the brain. It plays a significant role in the sleeping pattern of human beings. Secretion of melatonin in the human body decreases with age due to gradual calcification of the pineal gland. This phenomenon is responsible for causing insomnia in the elderly population. Recent studies indicate that the melatonin molecule is responsible for more than just regulation of sleep patterns and might be helpful in curbing other diseases including some forms of cancer. Melatonin can be synthesized synthetically and are available in the market as dietary supplements, medicine, and food and beverages, among others. However, various countries follow different laws regarding melatonin. In North America, melatonin is not regulated as a drug by the Food and Drug Administration (FDA), and is therefore available over the counter as dietary supplements, unlike in Europe and Asia Pacific, where it is mostly available as a prescription drug. Natural melatonin, which is extracted from animal, specifically bovine, pineal glands, is also available in the market. However, due to a higher risk of viral contamination, the natural melatonin market is niche and almost negligible at present.

The melatonin market has witnessed a tremendous growth over the past few years, particularly in North America, where awareness about melatonin, the lack of its side effects, and dietary supplement status have shaped its growth trajectory. Apart from these factors, the increasing stress level of the general population is a major driving factor for the market. 

Dietary supplements was the largest application segment for melatonin and is expected to exhibit continued and favourable growth rates in the foreseeable future. It is also expected to be the fastest growing application segment for melatonin. Since the market is mainly concentrated in North America, where melatonin enjoys dietary supplement status, major growth is expected to be derived from this region. Medicinal application of melatonin is highly concentrated in the Europe and Asia Pacific markets, as melatonin is not available over the counter without physician’s prescription. One of the most promising applications of melatonin is in the form of food and beverages. Several beverage manufacturers such as Bebida Beverage Company Ltd. have introduced melatonin laced beverages and ice creams in order to provide a calming and sedative effect to the consumer and act as a sleeping aid. Melatonin is also used as an active ingredient in brownies and other eatables, to provide the desired effect. The melatonin laced food and beverage market witnessed tremendous growth and popularity since its inception. However, as per FDA regulations melatonin is not safe to be used as a food supplement, and several manufacturers have received warning letters from the authority advising against the use of melatonin in food products.

In 2012, North America exhibited the highest demand for melatonin followed by Europe. These two geographies cumulatively accounted for more than 80% of the global demand. Although Asia Pacific market has high potential, the lack of awareness and regulated drug status of melatonin is a major hindrance.

The melatonin industry is fragmented in North America, with a large number of players in the market. However in Europe and some parts of Asia Pacific, Circadin is the only brand which has obtained marketing rights. Circadin is manufactured and marketed by different companies such as Flynn Pharma Ltd., Fidia Farmeceutici Spa, Aspen Pharmacare Ltd. and Takeda Pharmaceuticals International GmbH, among others, in different countries. Melatonin-laced beverage manufacturer Bebida Beverage Company Ltd. has recently expanded their geographical presence in order to cater to the Europe and Asia Pacific markets.

global-melatonin-market-share-by-application-2012-and-2019
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research